Japan Animal Referral Medical Center Co., Ltd. (6039.T)
JPY 2308.0
(0.44%)
JPY 2308.0
(0.44%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | 899.78 Million | 810.92 Million | 557.57 Million | 504.39 Million | 537.97 Million |
| Net Income | 491.3 Million | 533.93 Million | 423.58 Million | 411.99 Million | 312.81 Million |
| Depreciation & Amortization | 464.47 Million | 411.84 Million | 241 Million | 220.03 Million | 217.94 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | 109.66 Million | -72.53 Million | -12.24 Million | -7.02 Million | -42.58 Million |
| Other non-cash items | 76.77 Million | 87.57 Million | 46.56 Million | 36.36 Million | 482.63 Million |
| Investing Cash Flow | -985.86 Million | -784.06 Million | -1.42 Billion | -69.57 Million | -93.45 Million |
| Investments in PPE | -1.05 Billion | -741.93 Million | -601.93 Million | -65.5 Million | -87.87 Million |
| Acquisitions | 1.62 Million | 218 Thousand | -784.82 Million | 2.92 Million | 678 Thousand |
| Investment purchases | -32.06 Million | -131.46 Million | -119.05 Million | -107.04 Million | -106.19 Million |
| Sales/Maturities of investments | 100 Million | 100 Million | 100 Million | 100 Million | 100 Million |
| Other Investing Activities | -228 Thousand | -10.87 Million | -20.31 Million | 60 Thousand | -62 Thousand |
| Financing Cash Flow | -392.32 Million | 820.58 Million | 722.09 Million | -469.42 Million | -445.59 Million |
| Debt repayment | -119.13 Million | -53.72 Million | -847.61 Million | -329.83 Million | -430.18 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | -328.61 Million | - | -120.45 Million | -147.96 Million | -13.77 Million |
| Common Stock Issuance | 62.02 Million | 775.79 Million | 7.25 Million | 11 Million | 6 Million |
| Other Financing Activities | -761 Thousand | -2.77 Million | -10.2 Million | -2.4 Million | -7.62 Million |
| Accounts receivables | -33 Million | -34 Million | 2 Million | -4 Million | -1.93 Million |
| Accounts payables | -2.45 Million | 17.67 Million | -5.03 Million | -1.81 Million | 9.7 Million |
| Inventory | 15.49 Million | -40.86 Million | 15.04 Million | -9.91 Million | -4.7 Million |
| Other working capital | 152 Million | 63 Million | 17 Million | 35 Million | -45.64 Million |
| Cash at beginning of period | 1.81 Billion | 968.59 Million | 1.11 Billion | 1.14 Billion | 1.15 Billion |
| Cash at end of period | 1.33 Billion | 1.81 Billion | 968.59 Million | 1.11 Billion | 1.14 Billion |
| Capital Expenditure | -1.05 Billion | -741.93 Million | -601.93 Million | -65.5 Million | -87.87 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -478.4 Million | 847.44 Million | -146.07 Million | -34.6 Million | -1.06 Million |
| Free Cash Flow | -155.41 Million | 68.98 Million | -44.36 Million | 438.88 Million | 450.1 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 103 Million | 117 Million | 491.3 Million | 123 Million | 79 Million | 18 Million |
| Depreciation & Amortization | - | - | 464.47 Million | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | 109.66 Million | - | - | - |
| Other non-cash items | -103 Million | -117 Million | 76.77 Million | -123 Million | -79 Million | -18 Million |
| Investing Cash Flow | - | - | -985.86 Million | - | - | - |
| Investments in PPE | - | - | -1.05 Billion | - | - | - |
| Acquisitions | - | - | 1.62 Million | - | - | - |
| Investment purchases | - | - | -32.06 Million | - | - | - |
| Sales/Maturities of investments | - | - | 100 Million | - | - | - |
| Other Investing Activities | - | - | -228 Thousand | - | - | - |
| Financing Cash Flow | - | - | -392.32 Million | - | - | - |
| Debt repayment | - | - | -119.13 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -328.61 Million | - | - | - |
| Common Stock Issuance | - | - | 62.02 Million | - | - | - |
| Other Financing Activities | - | - | -761 Thousand | - | - | - |
| Accounts receivables | - | - | -33 Million | - | - | - |
| Accounts payables | - | - | -2.45 Million | - | - | - |
| Inventory | - | - | 15.49 Million | - | - | - |
| Other working capital | - | - | 152 Million | - | - | - |
| Cash at beginning of period | - | - | 1.81 Billion | - | - | - |
| Cash at end of period | - | - | 1.33 Billion | - | - | - |
| Capital Expenditure | - | - | -1.05 Billion | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | -478.4 Million | - | - | - |
| Free Cash Flow | - | - | -155.41 Million | - | - | - |
240810
6655
HYDR
6092
CRW
0315